Literature DB >> 12165494

The unique antigen receptor signaling phenotype of B-1 cells is influenced by locale but induced by antigen.

Michael J Chumley1, Joseph M Dal Porto, John C Cambier.   

Abstract

Normal animals contain an autoreactive B lymphocyte subset, the B-1 subset, which is controlled by undefined mechanisms to prevent autoimmunity. Using a V(H)11V(kappa)9 Ig transgenic mouse, with a specificity prototypic of the subset, we have explored conditions responsible for the previously reported Ag hyporesponsiveness of these cells. We report that peritoneal V(H)11V(kappa)9 B cells exhibit typical B-1 behavior with high basal intracellular free Ca(2+) and negligible receptor-mediated calcium mobilization. However, splenic B cells from this mouse, while phenotypically similar to their peritoneal counterparts, including expression of CD5, mount robust B-2-like responses to Ag as measured by calcium influx and altered tyrosine phosphorylation responses. When these splenic cells are adoptively transferred to the peritoneal cavity and encounter their cognate self-Ag, they acquire a B-1 signaling phenotype. The ensuing hyporesponsiveness is characterized by increases in both basal intracellular calcium and resting tyrosyl phosphorylation levels and is highlighted by a marked abrogation of B cell receptor-mediated calcium mobilization. Thus, we show that self-Ag recognition in specific microenvironments such as the peritoneum, and we would propose other privileged sites, confers a unique form of anergy on activated B cells. This may explain how autoreactive B-1 cells can exist while autoimmunity is avoided.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165494     DOI: 10.4049/jimmunol.169.4.1735

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  X-chromosome-linked immune-deficient mice have B-1b cells.

Authors:  J Riggs; K Howell; B Matechin; R Matlack; A Pennello; R Chiasson
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

2.  Normal B-1a cell development requires B cell-intrinsic NFATc1 activity.

Authors:  Robert Berland; Henry H Wortis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

3.  Polyreactive antigen-binding B (PAB-) cells are widely distributed and the PAB population consists of both B-1+ and B-1- phenotypes.

Authors:  Z-H Zhou; A L Notkins
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

4.  Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection.

Authors:  Vishal Sindhava; Michael E Woodman; Brian Stevenson; Subbarao Bondada
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

Review 5.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

6.  Successful treatment of Wegener's granulomatosis associated scleritis with rituximab.

Authors:  C M G Cheung; P I Murray; C O S Savage
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

7.  Cutting edge: inherent and acquired resistance to radiation-induced apoptosis in B cells: a pivotal role for STAT3.

Authors:  Dennis C Otero; Valeria Poli; Michael David; Robert C Rickert
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

8.  Btk regulates multiple stages in the development and survival of B-1 cells.

Authors:  Cristina M Contreras; Kristina E Halcomb; Lindsey Randle; Rochelle M Hinman; Toni Gutierrez; Stephen H Clarke; Anne B Satterthwaite
Journal:  Mol Immunol       Date:  2007-01-04       Impact factor: 4.407

9.  Mzb1 protein regulates calcium homeostasis, antibody secretion, and integrin activation in innate-like B cells.

Authors:  Henrik Flach; Marc Rosenbaum; Marlena Duchniewicz; Sola Kim; Shenyuan L Zhang; Michael D Cahalan; Gerhard Mittler; Rudolf Grosschedl
Journal:  Immunity       Date:  2010-11-24       Impact factor: 31.745

10.  Analysis of Wegener's granulomatosis responses to rituximab: current evidence and therapeutic prospects.

Authors:  Achille Aouba; Christian Pagnoux; Boris Bienvenu; Alfred Mahr; Loïc Guillevin
Journal:  Clin Rev Allergy Immunol       Date:  2007-09-12       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.